Steven Adams
Obstetrics & Gynecology · Idaho Falls, IDNPI 1174847198
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.9% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 48.1% of the total. Reporting peaked in 2021 at $491 and has fallen 89.6% since, to $51 in 2025.
Across 101 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$905
- Astellas Pharma US Inc$269
- Hologic Sales And Service, LLC$92
- Exeltis, USA Inc.$88
- Amgen$82
- Shield Therapeutics Inc$72
- plus $373 from 15 others
What the payments were for
- Food & beverage$1,76794%
- Education$1146%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 51 | $905 |
| Astellas Pharma US Inc | 8 | $269 |
| Hologic Sales And Service, LLC | 4 | $92 |
| Exeltis, USA Inc. | 5 | $88 |
| Amgen | 5 | $82 |
| Shield Therapeutics Inc | 4 | $72 |
| Merck | 3 | $56 |
| Lilly USA, LLC | 3 | $40 |
| Scynexis, Inc. | 2 | $37 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $37 |
| Biohaven Pharmaceuticals, Inc. | 3 | $37 |
| Boston Scientific | 1 | $27 |
| Aspira Women's Health Inc | 1 | $23 |
| Pfizer | 1 | $20 |
| Novo Nordisk | 1 | $20 |
| Organon | 1 | $16 |
| Axonics, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Roche Diagnostics Corporation | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Lupin Inc. | 1 | $11 |
How this compares
$1,881 in reported general payments places this provider in the 70th percentile of 166 obstetrics & gynecology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $131 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Idaho Falls
- Ty EricksonIdaho Falls$286K
- Jeffrey BakerIdaho Falls$18K
- Glenn LeavittIdaho Falls$17K
- Tauni EckersellIdaho Falls$3K
- Jeremy WhitingIdaho Falls$3K
- Steven RobisonIdaho Falls$3K
- Matthew RobisonIdaho Falls$2K
- Luke O RourkeIdaho Falls$2K
- Kim CoxPocatello$24K
- Kelly SiudzinskiMeridian$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.